Condition

Non-small-cell Lung Carcinoma

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 12 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials12
Recruiting0
Common interventions21
Lead sponsors shown12
Advertisement

Clinical trials

12 shown
Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid TumoursNCT05698238 · 2024-01-01
NOT_YET_RECRUITING
Phase II Study of SY-3505 in Patients With ALK-positive NSCLC Who Have Failed Prior Second-Generation ALK TKINCT05869162 · 2023-06-30
UNKNOWN
Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.NCT04737382 · 2019-08-22
UNKNOWN
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT03088540 · 2017-05-29
COMPLETED
The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence MonitoringNCT02647164 · 2016-01-01
UNKNOWN
Study of the Efficacy of SBRT on Unresectable Peripheral Primary TumorNCT02400424 · 2015-02-01
TERMINATED
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung CancerNCT01799161 · 2014-12-01
WITHDRAWN
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung CancersNCT01421953 · 2011-08-01
COMPLETED
Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)NCT00124280 · 2005-07-01
COMPLETED
A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)NCT00126451 · 2004-12-01
TERMINATED
A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00091663 · 2004-08-01
COMPLETED
PET Imaging in Potentially Surgically Resectable Non-small Cell Lung CancersNCT00136890 · 2004-07-01
COMPLETED

Common interventions

Trial status mix

COMPLETED5
UNKNOWN3
TERMINATED2
NOT_YET_RECRUITING1
WITHDRAWN1

Phase mix

NA3
PHASE23
PHASE33
PHASE12
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.